Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02523066

Enrollment

215

Registered

2015-08-14

Start date

2014-11-10

Completion date

2025-05-07

Last updated

2025-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Valve or Aortic Valve Replacement

Brief summary

Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese patients.

Interventions

DEVICEMagna Ease

This study is non-intervention

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* The patients who implanted with Magna Ease Heart Valve (Type:7300TFX and 3300TFX) in Fuwai Hospital in China. * The patients agree to sign the inform consent form (ICF).

Exclusion criteria

* No specific

Design outcomes

Primary

Measure	Time frame	Description
Echocardiography to evaluate the performance of heart valve	Up to five years after surgery	Subjects are required to do eight times echocardiography in follow up visits

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026